INFANRIX-POLIO+HIB

This brand name is authorized in Finland, Israel.

Active ingredients

The drug INFANRIX-POLIO+HIB contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Diphtheria toxoid UNII `3U7E3O07S8` - CORYNEBACTERIUM DIPHTHERIAE
	Read more about Diphtheria toxoid
`2`	Tetanus toxoid UNII `K3W1N8YP13` - CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)
	Read more about Tetanus toxoid
`3`	Pertussis toxoid
	Read more about Pertussis toxoid
`4`	Pertussis filamentous hemagglutinin UNII `8C367IY4EY` - BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)
	Read more about Pertussis filamentous hemagglutinin
`5`	Pertactin UNII `2QNL82089R` - BORDETELLA PERTUSSIS
	Read more about Pertactin
`6`	Poliomyelitis, serotype 1 UNII `0LVY784C09` - POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED)
	Read more about Poliomyelitis, serotype 1
`7`	Poliomyelitis, serotype 2 UNII `23JE9KDF4R` - POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED)
	Read more about Poliomyelitis, serotype 2
`8`	Poliomyelitis, serotype 3 UNII `459ROM8M9M` - POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)
	Read more about Poliomyelitis, serotype 3
`9`	Haemophilus influenzae type B polysaccharide UNII `F2TW0N64FI` - HAEMOPHILUS INFLUENZAE TYPE B
	Haemophilus influenza type B (Hib) is a bacteria responsible for severe pneumonia, meningitis and other invasive diseases almost exclusively in young children. Vaccines are the only public health tool capable of preventing the majority of serious Hib disease.
	Read more about Haemophilus influenzae B

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J07CA06	Diphtheria-Haemophilus influenzae B-pertussis-poliomyelitis-tetanus	J Antiinfectives for systemic use → J07 Vaccines → J07C Bacterial and viral vaccines, combined → J07CA Bacterial and viral vaccines, combined
Discover more medicines within J07CA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
FI	Lääkealan turvallisuus- ja kehittämiskeskus	059659
IL	מִשְׂרַד הַבְּרִיאוּת	4089

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.